Fabricio Ferreira de Oliveira, M.D., B.B.A, M.Sc., Ph.D.
Executive Medical Director
Elysian Clinic São Paulo, Brazil
Zahinoor Ismail, M.D. FRCPC
Professor of Psychiatry, Neurology, Epidemiology and Pathology
Hotchkiss Brain Institute and O’Brien Institute for Public Health
Cumming School of Medicine, University of Calgary
George Perry, PhD
The University of Texas at San Antonio
Ramit Ravona-Springer, MD
Tel Aviv University
|Credit Provided by||Rush University|
|Funding Statement||Earn complimentary CME credit.|
|Copyright Statement with Logo||Home Office
Alzheimer's Association National Office, 225 N. Michigan Ave., Fl. 17, Chicago, IL 60601
Alzheimer's Association is a not-for-profit 501(c)(3) organization.
© 2022 Alzheimer’s Association®. All rights reserved.
All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher.
This educational activity was planned and produced in accordance with the ACCME Accreditation Criteria, Policies and Standards for Commercial Support. Recommendations involving clinical medicine in a Continuing Medical Education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection and analysis.
This CME/CE activity might describe the off-label, investigational or experimental use of medications that may exceed their FDA- approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. RUSH University Medical Center requires the speaker to disclose that a product is not labeled for the use under discussion.
|Target Audience / Intended Audience||This activity is intended to meet the educational needs of psychologists, primary care clinicians including internists, family physicians, radiologists, neurologists, nurse practitioners and physician assistants who are seeking additional education in the assessment, diagnosis and ongoing health care of patients with cognitive impairment and dementia.|
|Statement of Need / Activity Purpose||
Research with biofluid biomarkers aims to establish objective associations with behavioral and cognitive changes, but depends upon anthropometric and sociodemographic variables that may affect the final results. Though neuropsychiatric syndromes may serve as proxy markers for neuropathological change, neuropsychiatric assessment must take human diversity into account. In this third webinar, we will discuss potential uses of biomarkers for neuropsychiatric diagnosis and drug response.
ACTIVITY - EN 450-0622
Upon completion of this webinar you will learn:
|Method of Participation||
This curriculum will take approximately 60 minutes to complete. To receive maximum credit, participants are required to view the presentation in its entirety. Upon completion of the activity and evaluation form, a certificate will be immediately available. There is no fee to participate in the activity or for the generation of the certificate.
For questions, contact Jodi Titiner at email@example.com
In support of improving patient care, Rush University Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC) to provide continuing education for the health care team.
Rush University Medical Center designates this internet enduring material activity for a maximum of one (1) AMA PRA Category 1 Credit™. Physicians should claim only credit commensurate with the extent of their participation in the activity. This activity is being presented without bias and with commercial support.
Rush University Medical Center designates this activity for one (1) CE credit in psychology. This activity is being presented without bias and with commercial support.
Disclosures- Faculty reports the following relationship(s)
Dr. Fabricio Ferreira de Oliveira discloses that consultancies to Gerson Lehrman Group, Atheneum Partners, Guidepoint, Rain Partners, Health Advances, and Lionbridge. All of the relevant financial relationships listed for the disclosures have been mitigated.
Dr. Zahinoor Ismail has no relevant financial disclosures.
Dr. George Perry has disclosed consultancies to NervGen and Synaptogenix, and is a stockholder in Synaptogenix and Neurotez. All of the relevant financial relationships listed for the disclosures have been mitigated.
Dr. Ramit Ravona-Springer has no relevant financial disclosures.
Dr. Claire Sexton, Alzheimer’s Association staff, has no relevant financial disclosures.
|Hardware and Software Requirements||
Hardware and Software Requirements